Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP)

Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (APP)

US Patent 6905832 · Granted Jun 14, 2005

Estimated economic value: $2,789,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ligand controling interaction between gags with their effector molecules and use2022
Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 2020
Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneratio2020
Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neur2019
Use of a reverse-transcriptase inhibitor in the prevention and treatment of dege2018
Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neur2018
Inhibition of the synthesis of beta-app or the activity of the A-β peptide in th2018
Use of the engrailed homeodomain protein as anxiolytic2013
Carrier vectors through an epithelium with tight junctions2012
Applications of peptides derived from the cytoplasmic domain of amyloid precurso2006
Applications of peptides derived from the cytoplasmic domain of amyloid precurso2006
Method for identification of target genes of transcription factors2003